title: Do activators of the κ-opioid receptor hold the potential for anti-arrhythmic drug development?
authors.forename: Jan
authors.initials: J
authors.lastname: Mersmann
authors.forename: Kai
authors.initials: K
authors.lastname: Zacharowski
mesh_terms: D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology* / Q000627:therapeutic use; D015415:Biomarkers; D018031:Connexin 43 / Q000187:drug effects* / Q000378:metabolism; D004195:Disease Models, Animal; D055808:Drug Discovery; D017202:Myocardial Ischemia / Q000097:blood / Q000188:drug therapy* / Q000473:pathology; D015428:Myocardial Reperfusion Injury / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D010766:Phosphorylation; D051381:Rats; D017473:Receptors, Opioid, kappa / Q000008:administration & dosage*
chemical_list: D000889:Anti-Arrhythmia Agents; D015415:Biomarkers; D018031:Connexin 43; D017473:Receptors, Opioid, kappa